Trading tissues for freedom: incentivizing stem cell and solid organ donation in the incarcerated population [0.03%]
囚犯捐献干细胞和实体器官的激励措施：用纸巾换取自由的权利
David M Chooljian,Jeremy W Jacobs,Brian D Adkins et al.
David M Chooljian et al.
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era [0.03%]
CAR-T时代自体造血干细胞移植功能受限时同种异体造血细胞移植治疗复发/难治侵袭B细胞淋巴瘤的作用
Alberto Mussetti,Leyre Bento,Mariana Bastos-Oreiro et al.
Alberto Mussetti et al.
Anti-CD19 chimeric antigen receptor T cells (CART) has rapidly been adopted as the standard third-line therapy to treat aggressive B-cell lymphomas (ABCL) after failure of second-line therapy despite the lack of direct comparisons with allo...
Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective cohort study [0.03%]
克罗拉滨和全身放疗作为高危急性白血病患者异基因干细胞移植前的预处理方案：一项来自两家中心的研究回顾性队列研究
Jean El Cheikh,Ghassan Bidaoui,Ali Atoui et al.
Jean El Cheikh et al.
Clofarabine (Clo) is an immunosuppressive purine analog that may have better anti-leukemic activity than fludarabine (Flu). The addition of total body irradiation (TBI) to conditioning regimens has been widely investigated. However, the use...
Observational Study
Bone marrow transplantation. 2023 Jun;58(6):667-672. DOI:10.1038/s41409-023-01947-z 2023
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE) [0.03%]
造血干细胞移植(HSCT)预后的生存评估：欧洲血液和骨髓移植协会(EBMT)与ISCT及EBMT联合认证委员会(JACIE)的持续项目的更新研究报告
Riccardo Saccardi,Hein Putter,Dirk-Jan Eikema et al.
Riccardo Saccardi et al.
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FAC...
Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey [0.03%]
欧洲2021年造血细胞移植和细胞疗法。SARS-CoV-2大流行的第二年。EBMT活动调查报告
Jakob R Passweg,Helen Baldomero,Fabio Ciceri et al.
Jakob R Passweg et al.
In 2021, 47,412 HCT (19,806 (42%) allogeneic and 27,606 (58%) autologous) in 43,109 patients were reported by 694 European centers. 3494 patients received advanced cellular therapies, 2524 of which were CAR-T treatments, an additional 3245 ...
Raphael A Fraser
Raphael A Fraser
We are pleased to add this typescript, Inappropriate use of statistical power by Raphael Fraser to the BONE MARROW TRANSPLANTATION Statistics Series. The authour discusses how we sometimes misuse statistical analyses after a study is comple...
Observational Study
Bone marrow transplantation. 2023 May;58(5):474-477. DOI:10.1038/s41409-023-01935-3 2023
CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality [0.03%]
移植前巨细胞病毒特异性免疫反应阳性的造血干细胞移植受者移植后巨细胞病毒再活化及死亡风险分析
Kirsten Alexandra Eberhardt,Verena Jung,Elena Knops et al.
Kirsten Alexandra Eberhardt et al.
Cytomegalovirus (CMV) represents one of the most common infectious complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Currently, a common diagnostic test used to stratify the risk for CMV infection in allo-H...
BleedHD-a new electronic assessment tool for grading chronic graft-versus-host disease validated in a multicenter and multiprofessional setting [0.03%]
BleedHD-多中心和多专业环境验证的慢性移植物抗宿主病电子评估工具
Andrea Warthmann,Andreas Holbro,Andreas Buser et al.
Andrea Warthmann et al.
Multicenter Study
Bone marrow transplantation. 2023 May;58(5):613-615. DOI:10.1038/s41409-023-01945-1 2023
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination [0.03%]
造血干细胞移植和细胞治疗受者接种疫苗一年后的抗体水平下降、加强针效果及突破性感染事件分析
José Luis Piñana,Rodrigo Martino,Lourdes Vazquez et al.
José Luis Piñana et al.
The kinetics of SARS-CoV-2 reactive IgG antibodies after full vaccination and booster in allogeneic and autologous stem cell transplantation (allo-HSCT, ASCT) and chimeric antigen receptor T-cell therapy (CAR-T) are of utmost importance for...
Multicenter Study
Bone marrow transplantation. 2023 May;58(5):567-580. DOI:10.1038/s41409-023-01946-0 2023
Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis [0.03%]
造血干细胞移植受者的心血管事件：系统评价和 Meta 分析
N Aghel,M Lui,V Wang et al.
N Aghel et al.
Cardiovascular diseases are an emerging cause of mortality and morbidity in survivors of hematopoietic stem cell transplantation (HSCT); however, the incidence of cardiovascular events (CVEs) in this population is not well described. This s...